Form 4: Carlyle Group Sells Shares of QuidelOrtho Corp Under 10b5-1 Trading Plan

The Carlyle Group executed multiple sales of QuidelOrtho Corp (QDEL) common stock between August 1st and 2nd, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Carlyle Group Inc. and related entities have reported the sale of QuidelOrtho Corp (QDEL) common stock.
• The transactions occurred on August 1st and 2nd, 2024.
• The sales were executed under a Rule 10b5-1 trading plan adopted on May 12, 2024.
• The sales prices ranged from $39.83 to $43.0003 per share.
• A total of 376,502 shares were sold directly.
• Following the reported transactions, Carlyle Partners VI Cayman Holdings, L.P. indirectly holds 8,724,346 shares.
• The Carlyle Group Inc. disclaims beneficial ownership of these securities.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing reporting share sales. It doesn't inherently convey positive or negative sentiment, but the market may interpret the sales based on their own analysis.

Future Outlook

The document does not contain any specific forward-looking statements regarding QuidelOrtho Corp's future performance.

Industry Context

The sale of shares by a major shareholder like Carlyle Group is a notable event that investors often monitor closely, as it can reflect the shareholder's view on the company's prospects and potentially impact the stock's trading volume and price.

Stakeholder Impact

• The share sales could potentially impact the stock price of QuidelOrtho Corp, affecting shareholders.
• The transactions do not appear to have a direct impact on employees, customers, suppliers, or creditors.

Key Dates